Quick Summary
- DuPont delivered Q1 adjusted EPS of 55 cents, surpassing analyst expectations of 48 cents
- Revenue reached $1.68 billion, marginally exceeding the $1.67 billion consensus forecast
- Annual EPS guidance upgraded to $2.35–$2.40 range, up from previous $2.25–$2.30 outlook
- Company unveils $275 million accelerated share repurchase program for immediate execution
- Management incorporates approximately 1% pricing adjustment to counter elevated input costs from Iran tensions
DuPont (DD) shares advanced 1.6% to $46.15 during premarket hours Tuesday following the specialty materials manufacturer’s impressive first-quarter performance and enhanced annual projections.
The company’s adjusted earnings per share reached 55 cents, significantly exceeding the analyst consensus of 48 cents compiled by FactSet. Revenue climbed to $1.68 billion from $1.61 billion in the year-ago period, narrowly surpassing the $1.67 billion analyst projection.
On a GAAP basis, DuPont returned to profitability with net income of $161 million, or 39 cents per share, a sharp reversal from the $589 million loss, or $1.40 per share, recorded in the comparable quarter of 2024.
Investors should consider that year-over-year comparisons are complicated by corporate restructuring. The company completed the spin-off of its electronics division, Qnity Electronics, which impacts historical comparisons.
Additionally, the first-quarter performance includes a three-cent-per-share benefit from discontinued operations associated with the Aramids business divestiture, which concluded on April 1.
Management Elevates Annual Outlook
DuPont increased its full-year adjusted EPS forecast to a range of $2.35 to $2.40, representing an improvement from the previously communicated $2.25 to $2.30 range. Revenue guidance also received an upward revision to $7.16–$7.22 billion, compared to the earlier projection of $7.08–$7.14 billion.
The updated guidance surpasses current Street expectations, which stand at $2.27 per share on revenue of $7.10 billion.
For the second quarter, management anticipates adjusted EPS of approximately 59 cents on revenue near $1.8 billion. This outlook aligns closely with analyst projections of 58 cents per share on $1.8 billion in sales.
CEO Lori Koch emphasized organic revenue growth, margin expansion, and double-digit adjusted earnings growth as key achievements in the quarter. CFO Antonella Franzen explained that the revised annual outlook incorporates approximately 4% organic growth, including roughly 1% from pricing actions designed to mitigate higher input costs stemming from the Iran conflict.
Capital Allocation and Business Unit Results
The company also revealed plans to execute a $275 million accelerated share repurchase program, commencing immediately. This initiative forms part of a comprehensive $2 billion buyback authorization approved by the board in November, which featured an initial $500 million accelerated component.
Across business segments, the Healthcare & Water Technologies division achieved 6% year-over-year sales growth, accompanied by a 1.1 percentage point expansion in operating margins. The Diversified Industrials segment recorded 3% revenue growth, also delivering a 1.1 percentage point improvement in profitability margins.
DD shares had declined approximately 9% since the outbreak of the Iran conflict on February 28, as market participants assessed the implications of elevated oil prices on production costs. Prior to Tuesday’s session, the stock maintained a 13% gain year-to-date and had appreciated 66% over the trailing twelve-month period.
The second-quarter projection of 59 cents adjusted EPS on $1.8 billion in revenue represents the company’s latest near-term guidance.
